TFX240719C210000
- 8.60
- 0.000.00%
Teleflex Newsroom
United States Sleep Apnea Devices Market Analysis Report 2024-2030 Featuring ResMed, Carefusion, Somnomed, Koninklijke Philips, Compumedics, Natus Medical, Teleflex, and Fisher & Paykel Healthcare - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Sleep Apnea Devices Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Types, Therapeutic Devices, Diagnostic Devices, End User, Cou
When Should You Buy Teleflex Incorporated (NYSE:TFX)?
Piper Upgrades Teleflex to Overweight, Cites Expected EPS Growth
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex Inc (NYSE:TFX) benefited in the first quarter from the surge in the interventional segment and other tailwinds.UroLift sales in the physician's office could bottom out at $49 million in 2024
Express News | Teleflex Shares up 3.6% After Piper Sandler Raises to Overweight From Neutral
Piper Sandler Upgrades Teleflex(TFX.US) to Buy Rating, Raises Target Price to $245
Piper Sandler analyst Matthew O'Brien upgrades $Teleflex(TFX.US)$ to a buy rating, and adjusts the target price from $205 to $245.According to TipRanks data, the analyst has a success rate of 51.1% an
Teleflex Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 16.48% Piper Sandler $205 → $245 Upgrades Neutral → Overweight 05/03/2024 4.12% Truist Securiti
Express News | Teleflex Inc : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $245 From $205
Teleflex Incorporated's (NYSE:TFX) Popularity With Investors Is Clear
Teleflex Incorporated's (NYSE:TFX) price-to-earnings (or "P/E") ratio of 31.8x might make it look like a strong sell right now compared to the market in the United States, where around half of the com
Express News | Teleflex Inc : RBC Cuts Target Price to $235 From $255
RBC Cuts Price Target on Teleflex to $235 From $255, Maintains Outperform Rating
Teleflex (TFX) has an average investment rating of hold among analysts polled by Capital IQ, with price targets ranging from $205 to $285.
Teleflex Has a Serious Balloon Catheter Recall, 3 Deaths Linked to Issue
Telix Pharma Pulls U.S. IPO Citing Market Conditions
Teleflex and Arrow Recall IAB Catheter Kits Due to Risk of Injury or Death
Express News | FDA:Total of 31 Injuries & 3 Deaths Have Been Reported Potentially Related to Manufacturing Issue of Arrow Fiberoptix and Ultraflex Iab Catheter Kits
Express News | FDA: Identified Teleflex/Arrow International's Recall Arrow Fiberoptix & Ultraflex Intra-Aortic Balloon Catheter Kits as Class I Recall
Express News | FDA: Teleflex/Arrow International Recall Arrow Fiberoptix and Ultraflex Intra-Aortic Balloon (Iab) Catheter Kits for Manufacturing Issue
Are Teleflex Incorporated's (NYSE:TFX) Mixed Financials Driving The Negative Sentiment?
With its stock down 7.0% over the past three months, it is easy to disregard Teleflex (NYSE:TFX). It is possible that the markets have ignored the company's differing financials and decided to lean-
Teleflex Incorporated's (NYSE:TFX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Peering Into Teleflex's Recent Short Interest
Teleflex's (NYSE:TFX) short percent of float has risen 46.73% since its last report. The company recently reported that it has 865 thousand shares sold short, which is 2.92% of all regular shares that